<DOC>
	<DOC>NCT01684852</DOC>
	<brief_summary>This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.</brief_summary>
	<brief_title>Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male or female person aged 18 years Demonstrated mild to moderate keratoconjunctivitis sicca ( "dry eye") Acute symptoms of dry eye: DEWS 13 tear breakup time TBUT &lt;10s agreement to abide by the routinely provided doctor's appointment for followup (reflected in the planned visits of observation plan resist) inflammation of the anterior segment or trauma Contact lens wearers Any disease that can, in the opinion of the treating physician to affect the outcome of the study. Patients with known intolerance to one of the substances used Surgical procedures to the eyes in the last 6 weeks before inclusion in the trial patients with addictive disorders or substance abuse fallow in the past 12 months, as well as persons incapable of giving consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop</keyword>
</DOC>